Travere Therapeutics, Inc. (NASDAQ:TVTX) filed its annual report (Form 10-K) with the Securities and Exchange Commission on February 19, 2026.
The Healthcare company reported annual revenue of and net income of for fiscal year 0.
Travere Therapeutics, Inc.'s stock currently trades at $29.30 with a market capitalization of $3.1B.